0 ratings0% found this document useful (0 votes) 46 views41 pagesDocument
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content,
claim it here.
Available Formats
Download as PDF or read online on Scribd
PHONE NO: 9419196999
E-MAIL: anilgupta@anphar.com
ANPHAR LABORATORIES PRIVATE LIMITED.
os REGD. OFFICE: INDUSTRIAL EXTENSION AREA, PHASE - Ill, GANGYAL, JAMMU
133112)K1987PTCO00930
metas ‘NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given that the 36!" Annual General Meeting of the Company will be held at the
registered office of the Company at Industrial Extension Area, Phase ~ i, Gangyal, Jammu on
Saturday the 30 of September, 2023 at 11.00 AM to transact the following business:
‘ORDINARY BUSINESS:
1. Toreceive, consider and addpt the Audited Financial Statement as at 31° of March, 2023 and
Statement of Profit and Lass for the year ended on that date and the Reports of the Board of
Directors and the Auditors thereon and the audited consolidated financial statements of the
company for the financial year ended 31* March, 2023,
By order of the Board
At
Place Jammu ‘ANIL GUPTA
Dated:04.09,2023 DIRECTOR
10897796
NOTES:
vote at the meeting instead of himself. A proxy need not be member of the company. A proxy to be
valid should be deposited with
general meeting of the company.
1. Amember entitled to attend and he at the meeting is entitled to appoint a proxy to attend and
company not tater than forty eight hours before the annual
2. Members/Proxies should All the| Attendance Slip for attending the Meeting and bring their
Attendance Slips to the Meeting.
3, ‘The instrument appointing the proky, in order to be effective, must be deposited at the Corporate
office of the Company, duly completed and signed, not less than 48 HOURS before the
commencement of the meeting, Prdxies submitted on behalf of companies, societies, etc, must be
supported by an appropriate resolution/authority, as applicable, A person can act as proxy on
behalf of shareholders not exceeding Sty (50) and/or holding in the aggregate not more than
10% of the total share capital of the Company. In case a proxy is proposed to be appointed by a
shareholder holding more than 10% of the total share capital of the Company carrying voting
"Fghts, hen such proxy shall not at as proxy for any other person or shareholder.
4, All relevant documents referred in this Notice shall be open for inspection by the Members at the
Registered office of the Company during the business hours on all working days upto the date of
AGM.
5. In terms of the requirements of the Secretarial Standard on General Meetings (SS-2) a route map of
the venue of the AGM is enclosedPHONE NO: 9419196999
E-MAIL: anilgupta@anphar.com
ANPHAR LABORATORIES PRIVATE LIMITED.
REGD. OFFICE : INDUSTRIAL EXTENSION AREA, PHASE - Ill, GANGYAL, JAMMU
CIN: U33112)K1987PTC000930
DIRECTOR'S REPORT
To
The Members,
Your Directors have pleasure in
Presenting their 36 Annual Report of the Company
together with the Audited Statements of Accounts for the year ended 31st March, 2023,
FINANCIAL RESULTS:
‘The Company's financial performance for the
figures are given hereunder:
PARTICULARS
Revenue From Operations
Other Income
Depreciation/Amortization
Net Profit/Loss before Tax
Provision for Tax
Deferred Tax
Net Profit/Loss after Tax
EPS
APPROPRIATIONS:
Adjustment Relating to Fixed
Assets
Transferred to General Reserve
/Statutory Reserve
Proposed dividend on Equity
Shares
‘Tax on dividend
year under review along with previous years
2023
(Amount in 00's.) (Amount in 00's)
1617288.70 1890073.62
63764.05, 59827.85
105847.36 68849.82
195012.85 416712.50
55876.84 104278.05
(3502.43) 3574.02
142638.43 308860.43
12.00 25.97
NIL NIL
NIL. NIL
NIL NIL
NIL. NIL
The Company has made strategic plans and established the Corporate strategy for ensuring
efficiency in order to increase the revenue from operations of the company.
DIVIDEND:
The Board of Directors of the company have not recommended any dividend for the year
under review
RESERVES:
ie Reserves & Surplus standing in the books of accounts amounting to Rs. 18,96,29,412/-
for the year ended on 31.03.2023
SHARE CAPITAL:
The Authorized Share Capital of the company is Rs. 1,20,00,000/- (Rupees One Crore
‘Twenty Lakh Only) divided into 12,00,000 equity shares of Rs. 10/- (Rupees Ten only) each
and the Paid Up Capital of the Company is Rs,
Lakh and Ninety Thousand and Eight Hundred
Rs. 10/- (Rupees Ten only) each.
1,18,90,800/- (Rupees One Crore Eighteen
Only) divided into 1189080equity shares ofDuring the Year, the Company has not made any changes in the Authorized or Paid Up Share
Capital of the Company.
MATERIAL CHANGES AND COMMITMENT IF ANY AFFECTING THE FINANCIAL
POSITION OF THE COMPANY OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR
TO WHICH THIS FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT:
No material changes and Commitment affecting the Financial Position of the Company have
occurred.
DIRECTORS RESPONSIBILITY STATEMENT
In accordance with the provisions of Section 134(5) of the Companies Act, 2013, the Board
of Directors hereby submits its responsibility Statement:-
(@) __ Inthe preparation of the annual accounts, the applicable accounting standards had
been followed along with proper explanation relating to material departures,
(b) The Directors had selected such accounting policies and applied them consistently
and made judgments aid estimates that are reasonable and prudent so as to give a
true and fair view of thé state of affairs of the company at the end of the financial
year and of the profit and loss of the company for that period;
(©) The Directors had taken proper and sufficient care for the maintenance of adequate
accounting records in ac¢ordance with the provisions of this Act for safeguarding the
assets of the company and for preventing and detecting fraud and other
irregularities;
(a) The Directors had prepated the annual accounts on a going concern basis; and
(©) The Directors had devised proper systems to ensure compliance with the provisions
ofall applicable laws and that such systems were adequate and operating effectively.
|
FRAUD REPORTING: ~
During the year under review nio instances of fraud were reported by the Company and by
the Statutory Auditors of the Company.
STATEMENT CONCERNING DEVELOPMENT AND IMPLEMENTATION OF RISK
MANAGEMENT POLICY OF THE COMPANY:
Business Risk Assessment procedures have been set in place for self-assessment of business
risks, operating controls and appropriate risk management policies are being framed to
cope up with any type of business risk.
DISCLOSURE:
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE
EARNINGS AND OUTGO:
‘The information pertaining to conservation of energy, technology absorption, Foreign
exchange Earnings and outgo a¢ required under Section 134 (3)(m) of the Companies Act,
2013 read with Rule 6(3) of the\Companies (Accounts) Rules, 2014 furnished in Annexure 1
Is attached to this report.
DETAILS OF POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON ITS
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES;
Anphar Laboratories Private Limited CSR initiatives and activities are aligned to the
requirements of Section 135 of|the Act. The brief outline of the CSR policy of the Company
and the initiatives undertaken by the Company on CSR activities during the year are set out
in Annexure | of this report in the format prescribed in the Companies (Corporate Social.
Responsibility Policy) Rules, 2014.PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186
OF THE COMPANIES ACT, 2013:
‘The Company has granted a loan of amount of Rs. 3,12,50,000/- to a company, AGRO TECH
AROMATICS PRIVATE LIMITED under Section 186 of the Companies Act, 2013 during the
year under review,
PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES:
‘The particulars of Contracts or Arrangements made with related parties made pursuant to
Section 188 is furnished in Annexure II is attached to this report.
DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE
(PREVENTION, PROHIBITION & REDRESSAL), ACT, 2013:
‘The company has always believed in providing a safe and harassment free workplace for
every individual working in the company through various interventions and practices. The
Company always endeavors to| create and provide an environment that is free from
discrimination and harassment |ncluding sexual harassment. The Company has in place a
robust system on prevention of sexual harassment at workpiace and it aims at prevention of
harassment of employees and lays down the guidelines for identification, reporting and
prevention of sexual harassment =
‘There were no complaints reported under the Prevention of Sexual Harassment of Women
at Workplace (Prevention, Proi{ibition and Redressal) Act, 2013 during the year under
review
‘THE DETAIL OF APPLICATION MADE OR ANY PROCEEDINGS PENDING UNDER THE
INSOLVENCY AND BANKRUPTCY CODE, 2016 DURING THE YEAR ALONG WITH THEIR:
STATUS AS AT THE END OF THE FINANCIAL YEAR:
During the year, there was no application made and proceeding initiated/ pending under
the Insolvency and Bankruptcy Gode, 2016, by any Financial and /or Operational Creditors
against your Company.
‘As on the date of this report, there is no application or proceeding pending against your
Company under the Insolvency ad Bankruptcy Code, 2016.
OF ONE TIME SETTLEMENT AND THE VALUATION DONE AT THE TIME OF TAKING
LOANS FROM BANKS OR FINANCIAL INSTITUTIONS ALONG WITH THE REASONS
THEREOF:
‘THE DETAILS OF Pane A THE AMOUNT OF VALUATION AT THE TIME
During the Financial Year 2022-28, the Company has not made any one time settlement with
its Bankers from which it has accepted any term Loan,
‘SECRETARIAL STANDARDS:
The Secretarial Standards Le $S+1& $S-2 relating to meetings of Board of Directors and
General Meeting respectively have been duly followed by the Company.
NUMBER OF BOARD MEETINGS|CONDUCTED DURING THE YEAR UNDER REVIEW:
‘The Company had 06 Board
financial year under review.
DEPOSITS:
‘The Company has neither accepted nor renewed any deposits during the year under review.
jeetings and 02 CSR Committee meeting during the
Particulars of Employees and Related Disclosures:
In terms of provisions of Section 197 of the Companies Act, 2013 read with the Companies
{Appointment and Remuneration of Managerial Personnel) Rules, 2014, during the year
under review there were no employees receiving remuneration in excess of the prescribed
limit as per the provisions of the Companies Act, 2013.STATUTORY AUDITORS/ AUDITOR'S REPORT:
‘The appointment of M/s Arora|Vohra & Co, Chartered Accountants, Jammu as Statutory
Auditors of the company to hold office for the period of 5 consecutive years i.e until the
conclusion of the 37 Annual Geperal Meeting to be held in the year 2024.
The Company has received a letter from them to the effect that their appointment, if made,
‘would be within the limit prescr
they are not disqualified for su
Companies Act, 2013.
Cost AUDITORS:
‘ped under Section 139 of the Companies Act, 2013 and that
fh appointment within the meaning of Section 141 of the
Pursuant to section 148 of the Spnpanies Act, 2013 read with the Companies (cost Records
and Audit) Amendment Rules, 2
on the Company.
ASSOCIATE COMPANY:
M/s. AGRO TECH AROMATH
ANPHAR LABORATORIES PRI
Act, 2013 which is holding 34,
129(3) read with the rule § of
1 (Annexure-lII} is attached wit
CONSOLIDATED FINANCIAL
/14, the maintenance of Cost Audit records is not applicable
IS PRIVATE LIMITED is a Associate Company of M/s
ATE LIMITED pursuant to Section 2[6) of the Companies
15% of Shares and the Form AOC-1 pursuant to Section
panies (Accounts) Rules, 2014 is furnished in Form AOC-
this report.
FATEMENTS:
In accordance with the Accountjng Standard (AS-21) on Consolidated Financial Statements
read with Accounting Standard
audited consolidated financial st
EXPLANATION OR COMMEN’
REMARKS OR DISCLAIMERS
‘There is no qualification, reser\
Auditors Report.
DIRECTOR
Ms. Sukriti Sharma got app:
review
ACKNOWLEDGEMENTS
(AS-13) on Accounting for Investments in subsidiaries, the
latements are provided in the annual report.
'S ON QUALIFICATIONS, RESERVATIONS OR ADVERSE
DE BY THE AUDITORS IN THEIR REPORTS:
ations or an adverse remark made by the Auditors in their
jnted for the post of directorship during the year under
|
Your Directors place on record their sincere thanks to bankers, business associates,
consultants, and various Goverfament Authorities for their continued support extended to
your Companies activities duri
gratefully the shareholders
ig the year under review. Your Directors also acknowledges
r their unstinted support and significant contributions
towards the growth of the company and confidence reposed in the Company. The Board of
Directors expects to receive the similar support and contribution from everyone in future
also.
Place :Jammu
Dated:04.09.2023
For and on behalf of the Board
\E
a a
ANKIT GUPTA ANIL GUPTA
DIRECTOR DIRECTOR
DIN: 06782180 DIN;00897796ANPHAR LABORATORIES PRIVATE LIMITED.
REGD. OFFICE : INDUSTRIAL EXTENSION AREA, PHASE - Il, GANGYAL, JAMMU
CIN : U33112JK1987PTCO00930
ANNEX TO DIRECTOR'S REP!
Information as per Section 134(3)(m) of the Companies Act, 2013 read with the Rule
8 of the Companies (Accounts) Rules, 2014 and forming part of the Director's Report
for the year ended 31-03-2023.
a) Conservation of energy
( [the steps taken of impact on conservation of | NIL
energy
(i) | the steps taken By the company for utilizing | NIL
alternate sources of energy 2
(ii) [the capital investment on energy conservation | NIL
equipment’s
(b) Technology absorption
())_| the efforts made towards technology absorption _| NIL ]
(ii) | the benefits derived like product improvement, | NIL |
cost reduction, product development or import
substitution I
(ii) in case of imported technology (imported during | NIL
the last three years reckoned from the beginning
ofthe financial year)-
(a) the details of technology imported NIL
(b) the year of import; ‘NIL
(©) whether the technology been fully absorbed __| NIL
(q) if not fully absorbed, areas where absorption | NIL
has not taken place, and the reasons thereof
(iv) [the expenditure incurred on Research and | NIL
Development
(c) Foreign exchange earnings and Outgo
The Company has foreign exchange inflow of Rs. 593068.79 however the Company has no
foreign exchange earning during the year under review.
For and on behalf of the Board
4 AES
Place Jammu ANKIT GUPTA.
Dated:04.09.2023 DIRECTOR ee
DIN: 06782180 DIN: eed
10089779613,
14.
15,
16.
ANPHAR LABORATORIES PRIVATE LIMITED
REGD. OFFICE : INDUSTRIAL EXTENSION AREA, PHASE - Ill, GANGYAL, JAMMU
CIN: U33112JK1987PTC000930
AN! = TOR’S Ri
I
conpoRaye SOCIAL RESPONSIBILTY POLICY
A brief outline of the company’s CSR policy, including overview of projects or
programs proposed to be undertaken:
Eradicating hunger, poverty and malnutrition, promotingpreventive health care and
sanitation and making available safe drinking water;
Promoting education, including special education and employment enhancing
vocation skills especially among children, women, elderly and other livelihood
enhancement projects;
Promoting gender eau: empowering women, setting up homes and hostels for
women and orphans; setting up old age homes, day care centers and such other
facilities.
Ensuring environmental sustainability, ecological balanice, protection of flora and
fauna, animal welfare, agro forestry, conservation of natural resources and
ynaintaining quality of soil, air and water;
‘Training to promote rural sports, nationally recognized sports, Paralympics and
Olympic sports;
Contribution to the Prime Minister's National Relief Fund or any other fund set up
by the Central Govern me for socio-economic development and relief and welfare
of the Scheduled Castes,/the Scheduled Tribes, other backward classes, minorities
and women;
Rural developmen pois
To carry out campaign, awareness programmes or public outreach campaign on
COVID-19 Vaccination pfogramme which includes the promotion of health care,
including preventive health care and sanitization, promoting education and disaster
management respectively.
Contribution to incubators or research and development projects in the field of
science, technology, engineering and medicine, funded by the Central Government or
State Government or Public Sector Undertaking or any agency of the Central
Government or State Govgrnment; and =
Contributions to public fyjnded Universities; Indian Institute of Technology (IITs);
National Laboratories ayd autonomous bodies established under Department of
Atomic Energy (DAE); Department of Biotechnology (DBT); Department of Science
and Technology (DST); Department of Pharmaceuticals; Ministry of Ayurveda, Yoga
and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH); Ministry of Electronics
and Information Techndlogy and other bodies, namely Defense Research and
Development Organisation (DRDO); Indian Council of Agricultural Research (ICAR);
Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial
Research (CSIR), engaged in conducting research in science, technology, engineering
and medicine aimed at promoting Sustainable Development Goals (SDGs),]17. Any other measures with the approval of Board of Directors on the recommendation
of CSR Committee subjecf to the provisions of Section 135 of Companies Act, 2013
and rules made there-uni
18. CSR VISION {
+ Develop meaningful and effective strategies for engaging with all stakeholders;
= Consult with local communities to identify effective and culturally appropriate
cevelopment goals;
+ Partner with credible | organizations like trusts, foundations ete. including
uon-government organizations;
+ Check and prevent pollition; recycle, manage and reduce waste, manage natural
resources in a sustainabl¢ manner;
+ Ensure efficient use of enfergy and environment friendly technologies;
2. ‘The Composition of the CSR Committee consisting of the following members:
Sno NAME OF DESIGNATION | NUMBER OF NUMBER OF
DIRECTOR MEETINGS OF | MEETINGS OF Cs
esncomauTree | COMMITTEE
HELD DURING ‘ATTENDED
{_‘tueyean __/ purine THE yean
OL. ANIL GUPTA, TT CHAIRMAN- 2 2
DIRECTOR |
02] ANKIT GUPTA DIRECTOR | 2 Zz
3. Details of Impact assessment of CSR projects carried out in pursuance of sub-
rule (3) of rule 8 of the Companies (Corporate Social Responsi
2014, if applicable : Not applicable
lity Policy) Rules,
4. Details of the amount available for set off in pursuance of sub-rule (2) of rule 7 of
the Companies (Corporate Social Responsibility Policy) Rules, 2014 and amount
required for set off for the financial year, ifany
S.NO FINANCIAL YEAR AMOUNT AVAILABLE | AMOUNT REQUIRED TO BE
} FOR SET OFF FROM|SET OFF FOR THE
PRECEDING FINANCIAL YEARS, IF ANY
FINANCIAL YEARS
a iL Tai - Nik x
Pursuant to Section 135 the provision of CSR Expenditure is not required to be made as the
net profits of the Company during the previous and current year is less than RS. 5.00 Crores
however the CSR Committee is committed to spend on unspent CSR amount of previous
years in order to fulfill its moral responsibility cowards the society.‘The Company was required to spent Rs.717646.43 towards Corporate Social Responsibility
being unspent amount of previous years. However the Company has spend Rs.7,50,000/-
in the following areas towards Corporate Social Responsibility.
we
‘SNO [Porrenononafrrs | AMOUNT (INRS)
ol. INDIAN INSTITUTE OF TECHNOLOGY RS.150000/-
|
02 DR.RISHT GUPTA MEMORIAL TRUST RS.2,00,000/-
103. SUNRISE EDUCATION TRUST RS.1,75,000/-
04. LUVIS BRONLLE SGHOOL RS.2,00,000/-
0S, LAGHU UDYOG BHARTI RS.25000/-
TOTAL T RS7,50,000/-
|
5 (a) CSR amount spent or unspent for the financial year:
‘Total Amount | AMOUNT UNSPENT.
Spent For The
Financial Year [Total Amount) Amount transferred to any fund
transferred to Unspent} specified under Schedule VII as per
CSR Accoynt as per | second proviso to Section 135(5) of the
Section 135{6) of the Act _| Act
Amount | Dateot ‘Name of | Amount Date of
ansfer the Fund Transfer
|
NIL nie lak Ni [NIL NIL.
1
b) Details of CSR amount spent against ongoing projects for the financial vear: NIL
ae To Te eT T9 [A © @ By @
Sno | Hane | Hem | Local [Locatio| | Project | Amount | Amount | Amount Mode of [Mode of
ofthe | from J area | nofthe | Duratio | allocated | spentiathe | transferred to | Impleme } impleme
projec | urelise | (¥es/n | project, | n forthe | eurrone —{ UnspentcsR | ntation | ntation-
ve fot ° project | financiat | accouncfor dhe | Direct | Through
aetivitie vyeat projectas per _| (Yes/No) | Impleme
sia Section 135(6) oF ning
Schedul the Act Agency
evitto
_ the Act _|
1 1
EC |Details vent against other than ongoin, cts ial vea
aye GB) @ G) a (10) ay
S. | Name ofthe ‘item from the Lodai Location of the project ‘Amount ‘Mode of | Mode of
no | protect listof activites | ae Speatfor | tmpleme | tmplementatio
inSehedulevit | (eno) the project | ntaion= | n- Through
tothe act Dice | aplemercing
IL tvesynoy | agency |
I | ‘State/UT District |
lt 4 i c | c
(a) Amount spent in Administrative Overheads: ‘NIL
(e) Amount spent on Impact Assessment, if applicable: NIL
(9) otal amount spent for the Financial Year (86+8¢+8d+8e) : NIL
_{g) Excess amount for set off, any :NIL
S.NO_ PARTICULARS, AMOUNT.
i) ‘Two percent ofavefage net profit of the NIL
Company as per Seétion 135(5) of the Act
ii) ‘Total amount spend for the Financial Year NIL.
iii) Excess amount spept for the financial year NIL
§Gi)-())
i) Surplus arising out of the CSR projects or NIL
programmes or activities of the previous
financial years, ifam
vy) ‘Amount available fbr set offin succeeding NIL
Financial years {(iii)-(iv)]
6 {2} Details of Unspent CSR amount for the preceding three financial years: Rs.
717646.43 |
i
Se PRECEDING ‘moa ‘uount | Amount transforced to any | Amount
No | FINANCIAL YEAR | wansferved | spenein the | fund specified under | remaining
to Ujspene | reporting} Schedule Vit as per Scetion | 29 be spent
CSR Adcoune | Financial | 135(6) ofthe Act ifany m
under Year succeeding
Section 135 ial
i atte years
2020-24 Tora | sae7aza I Ni
2. | 2023-22 350935.99 | 380933.96 NL
TOTAL [rirosgas | 71760645 I i
9. in case of creation or acquisition of capital asset, furnish the details relating to the
asset so created or acquired through CSR spent in the financial year (asset wise
details)
(a) Date of creation or acquisition of the capital asset(s) : None
(b) Amount of CSR spent forlcreation or acquisition of capital asset : NIL©) Details of the entity or public authority or beneficiary under whose name such
capital asset is registered, their address, etc. : Not Applicable
{d) Provide details of the capital asset(s) created or acquired (including complete
address and location of the capital asset) : Not Applicable
11. Specify the reason(s), if fhe Company has failed to spend two percent of the
average net profit as per Section 135(5) of the Act:
‘this year the Company does not fall under the preview of the provision of CSR as the
profits of the Company are less than Rs.S Crore . However the management is
committed to its social respogsibility and do spend funds in the CSR activities so as
to contribute something for sdcial cause.
For and on behalf of the Board
a Ae
Pface Jammu ANKIT GUPTA ‘ANIL GUPTA
Dated:04.09.2023 DIRECTOR DIRECTOR
DIN: 06782180 DIN:00897796ANPHAR LABORATORIES PRIVATE LIMITED.
REGD. OFFICE: INDUSTRIAL EXTENSION AREA, PHASE - Ill, GANGYAL, JAMMU
CIN: U33112JK1987PTCO00930
ANNEXU REI TO DIRECTOR'S REPORT
Form AOC-1
{Pursuant to first orovisofo sub-section (3) of section 129 read with rule 5 of
Companies (Accounts) Rules, 2014}
Statement containing salient faatures of the financial statement of subsidiaries/associate
companies/joint ventures
Part "A": Subsidiayies
{Information in respect of each subsidiary to be presented with amounts in Rs.)
S.No. Particulars Details
01. | Name of the subsidiaf NIL |
02. | Reporting period for the subsidiary NIL i]
concerned, if different from the holding
company’s reporting|period |
03. | Reporting currency ahd Exchange rate ason_[ NIL
the last dave of the relevant Financial year in
the case of foreign subsidiaries
04, [Share capital NIL.
| 05._| Reserves & surplus NIL
| 06._| Total assets [ ‘NEL
| 07. | Votal Liabilities NIL.
Q8._| Investments NIL
09, [Turnover NIL
10._| Profit before taxatioh NIL
11.__| Provision for taxation NIL
42. | Profit after taxation | NIL
13. [Proposed Dividend NIL
14. [% of shareholding | NIL.
Notes: The lig inernfon shall be furnished at the end of the statement:
1. Names of subsidiaries whidh are yet to commence operations
2. Names of subsidiaries which have been liquidated or sold during the year.Part “B": Associates and Joint Ventures
Statement pursuant to Section 129 (3) of the Companies Act,
Associate Companies and Joint Ventures
2013 related to
Name of associates/Joint Ventures AGRO TECH | NIL NIL
AROMATICS
| PYTLTD.
Latest audited Ralance Sheet Date 51.03.2023 | NIL; NIL
Shares of Associate /Joint Ventures Held by the
company onthe yearend |
No. of shares I 235000 NIL Nit
‘Amount of Investment in Associates/Joint 2350000, ‘NIL NIL
Venture
Extend of Holding % 34.05% NIL Nit
| Description of how there is significant Nile NIL NIL
influence
Reason why the associate/joint venture tsnot_| NIL Wil Nit
consolidated {
[Net worth attributable to shareholding as per | 1993097.662 | NIL NIL
Jatest audited Balance Sheet
[_ NIL NIL NIL
Profit Loss or the year (24268600) _| NIC NIL
(Considered in Consolidation 442606.00 | NIL Nit |
[Not Considered in Consolidation | Ni NIL [NIL J
1. Names of associates or joint
2. Names of associates or joint
\
Place :Jammu
Dated:04.09.2023
entuses which are yet ¢o commence operations.
tures which have been liquidated or sold during the year.
For and on behalf of the Board
}ie oe
ANRIT GUPTA ANIL GUPTA
DIRECTOR DIRECTOR
DIN; 06782180 DIN:00897796
M/s Arora Vohra & Co.,
(Chartered Accountants)
FRN: 09847N
ingh Sethi
‘Accountant)
M.No: 091188Form for disclosure of particula
ANPHAR L
REGD. OFFICE
ORATORIES PRIVATE LIMITED
INDUSTRIAL EXTENSION AREA, PHASE - III, GANGYAL, JAMMU
CIN: U33112)K1987PTCO00930
| FORM AOC-2
ANNEXURE II TO DIRECTOR'S REPORT.
{Pursuant to clause (h) of sub:section (3) of section 134 of the Act and Rule 8(2) of the
Companies (Accounts) Rules, 2014}
of contracts/ arrangements entered into by the company
with related parties referred to in sub-section (1) of section 188 of the Companies Act, 2013
including certain arm’s length teqnsactions under third proviso thereto.
1. Details of contracts or aruecpers or transactions not at arm’s length basis-NIL
2. Details of contracts or arranger
ents or transactions at arm's length basis:
Name(s) of | Nature of Nature of Duration | Salientterms of | Date(s) of
therelated | relationship | corftracts/ _| of the the contracts or | approval by
party arrangements | contracts/ | arrangements or | the Board/
/ arrangeme | transactions Members of
trahsactions | nts/ indudingthe | the
transactio | value, ifany ‘company
ns
ANILGUPTA | DIRECTOR | SALARY SYEARS | RS. 84,00,000/- | 20.12.2020
ANKIT DIRECTOR | SAUARY SYEARS | RS. 60,00,000/- | 20.12.2020 |
GUPTA
‘ANIL GUPTA | DIRECTOR softs ANNUALLY [RS.7,00,000/- | 05.06.2022
ANKIT DIRECTOR | BONUS ANNUALLY | RS.5,00,000/- | 05.06.2022
GUPTA.
ARPITA CHIEF SALARY SYEARS | RS.6,00,000/- | 05.06.2020
GUPTA EXECUTIVE
OFFICER
ANKIT DIRECTOR | RENT ANNUALLY | Rs, 12,00,000 | 05.06.2022
GUPTA —
‘AGRO TECH | RELATED CORPORATE RS, 5,00,00,000/} 04.03.2020
AROMATICS | CONCERN LOAN
PRIVATE
LIMITED
| For and on behalf of the Board
Place :Jammu ANKIT GUPTA ‘ANIL GUPTA
Dated:04.09.2023 DIRECTOR DIRECTOR
DIN: 06782180
DIN:00897796ARORA VOHRA & CO.
CHARTERED ACCOUNTANTS
INDEPENDENT AUDITORS’ REPORT
THE MEMBERS OF ANPHAR LABORATORIES
PRIVATE LIMITED
Report on the audit of the financial
statements
Opinion
We have audited the accompanying financial
statements of Anphar Laboraiqries Pvt
{go('the Company", which comprise the
ance sheet as at March 31, 2023, and the
Statement of Profit and Loss: for) the year
then ended, and notes to tne) financial
siatemenis, including a summary of
significant accounting policies ahd other
expianatory information {hereinaftey referred
to as the financial statements)
Tw our opinion and to the best of our
information and according tothe
aeplanations given to us, the aforesaid
financiai Statemenis give tiv information
vert by the Companies et, 2013 (‘Act’)
the manner so required and give a true
fir view in conformity jwith th
accaunting standards provided under
section 152 of the Companies Act 2013 read
with the Companies (Accounting Standacd)
tales 2021 (AS') and. other accounting
principies generaliy accepted in thdia , of
Sota of affairs of the Company as at
ih $1, 2023. and ils profits far the year
for epinion
We conducted our audit in accordance with
the standards on auiditing specified under
section 143 (19) of the Companies Act, 2013
Our responsibililios under those Standards
sed in the) Audlivoe’s
ara f,ither dese
responsibilities for the audit of the financial
statements section of our report. We are
independent of the Company in accordance
with the code of ethics issued by the
Institute of Chartered Accountants of india
‘together with the ethical requirements (ICAI)
that are relevant to our audit of the financial
statements under the provisions of the Act
and the rules made thereunder, and we have
fulfilled our other ethical responsibilities in
accordance with these requirements and the
ICAI code of ethics.
We believe that the audit evidence we have
obtained is sufficient and appropriate to
provide a basis for our opinion on financial
statements,
Emphasis on Matter Paragraph
We draw the attention to Note no: 18
Employee Benefits (Gratuity Plan)
Annexed in Notes forming Part of
Balance sheet:
Company is in process of registration of
Gratuity Teust for Employees Group Gratuity
‘Assurance Scheme entered into with the Life
insurance Corporation of tncia (LIC) trustees
with the Income Tax department as on the
cate cf audit.
Our opinion is not modified on the above
matter.
Key audit matters
Key audit matters are those matters that, in
out professional judgment, were ef most
significance in our audit of the finandal
statements of the current period. These
matters were addressed in the context of our
audit of the financial statements as ¢ whole,
and in forming our opinion thereon, and we
do not provide a separate opinion on these
matters
Page tofARORA VOHRA & CO.
CHARTERED ACCOUNTANTS
Reporting of key audit matters ag per SA
701, Key Audit Matters are nat applicable to
the Company as itis an unlisted company.
Information other than the financial
statements and auditors’ report thereon
The Company's board of diréctors is
responsible for the preparation presentation
of its report (hereinafter calied 4s “Board
Report’) which comprises. various
information required under section|134(3) of
the companies Act, 2013THE other
information comprises the information
included in the Board's Report jincluding
Annexures to Board's Repost, | Business
Responsibility Report but does not include
ihe financial statements and our! auditor's
report thereon,
Our opinion on the financial slatements
does not cover the Board Report pnd other
information and we do not copresd any form
of assurance conclusion thereon,
In connection with our audit of the financial
statements, our responsibility is to read
Boards Report and other information and, in
doing 50, consider whether the Board Report
and other information is |materiaily
inconsistent with the financial staiements or
cur knowledge obtained during the course
of our audit or otherwise appears to be
materially misstated.
If, based on the work we have performed, we
conclude that there is a material
misstatement in the Board Repost or other
information, we are required to feport that
fact, We have nothing to repr inthis
tegerd
Management's responsibility for the
financial statements
The Company's board of directors are
responsible for the matters stated in section
134 (5) of the Act with respect to the
preparation of these financial statements
that give a true and fair view of the financial
position financial performance of the
Company in accordance with the accounting
principles generally accepted in India,
including the accounting standards specified
under section 133 of the Act This
responsibility also includes maintenance of
adequate accounting records in accordance
with the provisions of the Act for
safeguarding of the assets of the Company
and for preventing and detecting frauds and
other irrequiarities; selection and application
of appropriate accounting policies, making
judgments and estimates that are reasonable
and prudent; and design, implementation
and maintenance of adequate internal
financial controls, that were operating
effectively for ensuring the accuracy and
completeness of the accounting records,
relevant to the preparation and presentation
of the financial statement that give a true
and fair view and are free from material
misstatement, whether due to fraud or error.
In preparing the financial statements,
management is responsible for assessing the
Company's ability to continue as a going
concern, disclosing, a8 applicable, matters
related to going concern and using the
going concer basis of accounting unless
management either intends to liquidate the
Company or to cease operations, or has no
realistic alternative but to do so.
The board of directors are also responsible
for overseeing the Company's financial
reporting process.
Page 2 of 64 | ARORA VOHRA & CO.
CHARTERED ACCOUNTANTS
Auditor's responsibilities for the audit of
the financial statements
Our objectives are to obtain réasonable
assurance about whether the | financial
statements as a whole are free from material
misstatement, whether due te fraud or error,
and to issue an auditor's report that includes
our opinion, Reasonable assurance|is @ high
level of assurance, but is not a guarantee
that an audit conducted in cad ce with
SAs will always detect a | material
misstatement when it exists. Misstatements
can arise from fraud or error and are
considered material if, individually or in the
aggregate, they could reasonably be
expected to influence the ‘Teonomnie
decisions of users taken on the basis of
these financial statements.
As part of an audit in accordance| with SAs
we exercise professional judgment and
maintain professional skepticism throughout
the audit, We also:
nisstatement of the financial spatements,
wivether due to fraud or error, design and
perform audit procedures eee to
those risks, and obtain auait evidence
that is sufficient and appropriate to
provide a basis for our opinion, The risk
of not detecting a material: misstatement
resulting from fraud is higher than for
‘one resulting from error, as fraud may
nvoive collusion, forgery, intentional
‘omissions, mistepresentations, or the
oveitide of internat control
Obtain an understanding of internal
-
RADE PAYABLES -
5) SUNDRY GREDTTORS 288,502.58 121,027.85,
se seer |
38,200.20
39.540,70,
3793 | 88187
23,500.09
to 20
13,082.72
13,082 72]
[|
4163491
34,727.06
72,000.00
[Nore
[ CONS TERWILOANS AND ADVANCES
LOANS AND ADVANGES TO RELATED PARTIES
LOAN YO SUBSIDARY COMPANY
{OROTECH AROMATICS PRIVAYE LINED)
noresg
(CORRENT INVESTMENTS
a
cS
12;500.00
72 500.00 |“RNPHAR LASORATORIES PRIVATE LWNTED —
"SCHEDULE FORMING PART OF BALANGE SHEET AS
IRieenTORIES : :
RAW MATES 24290838, saa250 78
DRORGINPROGRESS 79.2980 77 080.58
} cifinise0 6000s t 98,342.24 79,351.28
Ec gi stsse | ero 2
TRADE RECEIVABLES: :
‘a1 Seeunod, Considorad goed :
wilh elteu panies .
path ones 35121663 359,008.37
(b) Unsecured, consiseree goos : .
| ch ented partion : :
i
t
wores :
sah thers
{) Douottut :
si cates panies
||
LAST AND CASH COUIVALENTS:
25a, ws BANK siarrer agora
Broetrennd 2739 Pera]
[eo moRamsenp, Hore ¢ ec suazonty 03892
sie 25206
{ sore.
SHORT Ten LOANS AND ADVANCES
SHOANS AND ADVANGES (141) se.seo.0e 19.106 68
SyotenS GOVT 2) bessiose 27000,
_ _ — sre [5,107.28 |FANPHAR LABORATORIES PRIVATE LIMITED,
| SCHEDULE FORMING PART OF P&L ACCOUNT FOR THEYEAR ENDEO $1-052025
a PARTICULARS | CURRENT YEAR ‘PREVIOUS YEAR
wore
REVENLE HROM OPERATIONS
SAVF-OF PRODUCTS 1.820.788.70 1,990,07362
CESS CREDA NOTE 3500.00, :
c yer 388.70} Tmo]
wore38 =
OTHER INCOME : i
]OTHER NONOPERATING INCOME | 6376405, seers
33,768.05 55.77.85 |
nor
COST OF MaTERIAL CONSUMED i
RAW MATERIAL i
ope niNG S10C« 14425875 180,818.90,
4.28975 169.5180
rurchases gasaanes 863.507 50
O35a28aT “eeu 50750
css CLOSING sT0cK 22908 38 1.95975
I 836,689.87. 889,066.66,
| norsico -
| CHANGE ININVENTORIES :
‘oP, 306K : :
FinsHeD Coops raa5n20 1550000
‘WOK PROCESS 2109058 26,12000
A r ‘wogat.r1 | anzz000|
cLosiNe sT00K :
sr GOODS 55,302.24 7.38123
‘WORKIN PROCESS 73235.00 27.080 54
| 8 “zasrrz4 oo,eat 77
| vaRIATION WisTocK (AB) 29,195 48) zat
(area >
lgPLOVEE BENEFIT EXPENSES. :
| 2) SALARIES & INCENTIVES.
Snuany 49,184.43, 124,097.02
j wages 1420301 “417295
| GoNeYANOE / PETROL EXPENSE 204910 74.50
| tesve sa.aey 201659 4.82500
BONUS STAFF AND OIRECTOR soe 21,973.00
SECURITY 437348 Basra?
OVER TIME 9.13808 81088.00
b} CONTRIBUTIONS TO. :
| ADMINISTRATIVE EXP BF 36601 38487
EMPLOYER CONTR. PF 4.986 95 :
EP S CONTIBUTION PENSION AIC 357390
LINKED WSURANCE 238.81 28.20
INCENTIVES ON SALES 3.23458
| 22OVDENT FuND CONTRIBUTION 4907 89
UIPLOYER CONTR. ES! asrer 2293.42
DIRECTOR REMURERATION 144,000.00, 180.%00.00
ena tiaty CONTRIRUTION 119038
SE waza"ANPHAR LABORATORIES PRIVATE LIMITED.
‘SCHEDULE FORMING PART OF P&L AIC FOR THE YEAR ENDED 34-03-2023
PARTICULARS CURRENT YEAR | PREVIOUS YEAR
NOTE 17.4
OTHER NON-OPERATING INCOME }
EXPORT INCENTIVE 9.57.38 14,780.49
INTEREST SUBVENTION : 087
INTEREST ACCRUED HDFC/ UCO & PNB 3.53462 :
INTT. RECEIVED ON FDR 25,986.03 23,657.64
EXCISE DUTY REFUND - -
FOREIGN EXCHANGE DIFF 15,862.32 16,182.03
‘GST REFUND 3,332.10 3,841.00
MISC INCOME 5,491.59 4,688.12
REBATE & DISCOUNT / SHORT & EXCESS : 2
| : :
| 63,764.05 58,527, 85
NOTE? rs
INTEREST EXPENSES : :
INTEREST ON CIC | - -
BANK CHARGES 1,351.74 4,607.23
INTT. ON HDFC CAR LOAN AC : 12.43,
INTT. ON AOFC . 1,563.60,
INTT. PNB - -
INTT. ON TIL & POFC AIC 4.74
Tosa 3,185.00
NOTE 22.4 - =
OTHER EXPENSES ~ ~
LABORATORY EXPENSES 8,473.78 8,433.22
COMPUTER EXPENSES 739.62 ‘969.00
OTHERS (INCLUDING AMC} 4,253.75 3,048.20
70,467.14 72,450.42,
CONTRACT WAGES & OTHER SHARGES
WORKMEN WELFARE EXPENSES 4,203.04 4,172.93
4,203.07 4,172.93
FREIGHT & CARTAGE CHARGES =
‘CARRIAGE & FREIGHT 17,758.44
26,847.41
UNLOADING CHARGES 2,519.64 2,181.31
CARRIAGE) FREIGHT ON SALE 4,890.27
7028.72
550.00
300.00
[50.00]
“650.00
PAYMENT TO THE AUDITORS
STATUTORY AUDIT FEE
INTERNAL AUDIT FEE
POWER & FUEL s
OIL & LUBRICANTS 21,774.98 24,419.56
ELECTRICITY EXPENSES 412,634.04 41,176.54
34,409.00 36,596.10
TELEPHONE, POSTAGE & COURIER CHARGES - -
TELEPHONE EXPENSES 649.73 701.01
POSTAGE & COURIER CHARGES 4,226.44 918.73
| 1,876.17 7818.74
TRAVELLING & CONVEYANCE : -
DOMESTIC TRAVELLING EXPENSES 2,555.59 2,565.33
FOREIGN TRAVELLING EXP - -ANPHAR LABORATORIES PRIVATE LIMITED.
‘SCHEDULE FORMING PART OF P&L A/C FOR THE YEAR ENDED 31-03-2023,
PARTICULARS: CURRENT YEAR | PREVIOUS YEAR
2,555.59 2,565.33
MISCELLANEOUS EXPENSES :
CAR RUNNING & MAINTENANCE 5,808.40
REPAIR AND MAINTENANCE 14,068.64 :
CSR EXPENSES 7,500.00 8,250.00
LEGAL EXPENSES 303.60 1.17785
MISC. EXPENSES 8416.06
FILING FEE CHGS -
MEDICAL REIMBURSEMENT 1,780.50
INCENTIVE ON SALE .
DUTIES & TAXES :
SUBSCRIPTION & MEMBERSHIP FEE 244.00
INPUT TAX REVERSAL IN BOOKS 4430.32
OTHER EXPENSES, 19,876.05
‘SHORT & EXCESS, -
ROUND OFF 3.85
CHARITY AND DONATION 190.00
WATER EXPENSES 308.60
RESEARCH & DEVELOPMENT 498.80CANDHAR LABORATORIES PRIVATE LIMITED
"SCHEDULE FORMING PAFT OF PAL. ACCOUNT FOR THE YEAR ENDED 34.05.2028
- “PARTICULARS CURRENT YEAR FREVOUSTERR
NOTE :
Financial COSTS :
a) NTEREST exPeNs \ sas 74 38500,
5} CHER BORROWANG COSTS :
EIABPLIGABLE HEY GAINILOSS ON FOREIGN CURRENCY
eansac TIONS AND TRANSLATION
L = Sw
sores
Orne expenses :
EONSUMPTION OF STORES :
OTHER EXPENSES WEG weanise
PACING EXP ascast 400120
EXPORT 21 EARING & FORWAROING 203575 2m
POweA FUEL 342080) 38596.10
REPAlE & MARTENANCE .
BURLING esr8e5 433019
wACHINERY 2526
omires 10467 14 1245042
surance aster «ara
[estat exes 30570 531027,
AoE BERN | 52878 098.34
| snes coumssion pureed nan
EAU: S PROMOTION Exe 21897 :
Least RENT 1200000 2800 09
Rate SHES 4.13078 208 56
snes AND DISCCUNT (259.69)
| feawvetuiesa cowe vance 2588 59 2985.33
PREGGrUCARTAGE CHARGES 228833 soar
[gonsuirener es Tis 8 2397783
PRINTING & STATIONERY \ ‘500.00 e191
| raniext to mk AvonOR 50.00 35000
TELEF ONE, POSTAGE & COURIER CHARGES 1976.7 181074
sMSCELLANEOUS EXPENSES, 6297973, 2299427
| Bir 95325, 59855TS STS ea eee aE wa
wa | eexect sez coserr — foosies costes woe rat 2801
theses | st esee sossee ressee | Seoooze Seoeez0 wo
sare | soies ‘9629 Woes | soaure rscsve sive 38 99
sssoes | cesseo. su seems | secsne. seacre soreva: wsinance
‘orost seh zisice | iz ior prise seeety manodianoo sw
ore se60 seas” | gases ananeind3 Suis 3
esse 9058 s5 600% woes
| osiee ise zones see
jzoree see feese :
ss wees cosy sees wears
toscor resechs sans oeseazoe seceest 22001 38
Gio. Seone'st eseees 3 ss 59998
oes fore
scare
‘somets
feau 200097 inronnno4)-03Niaoan
sneazua_| Vo oe ee oe oo 1o0e vee “Ssonnoe
boos Groiweze | preerros—————__ae.gou ad
a voor sees : seces ~NangoTnse saree
z 20600 T —
[ eeccense “eoec0%0 | opcove wea reores [eco eOHE VS ays gnciitaoy zur iv sv swnouuve
|saktetan soatoton) Smee autod'aaa aerate | Ssoracsous Bone stoe8
#3108
(.ymiod MAN wad SY) £20z HOUVIN LSLC No sv $138S¥ 93X14 4O SUVLNG
s
GALIWIT BLVARId SANIOLVACAV wYHANYWN ve ve ww Tuounona Piaso WoL kaesse] rr
yEune:240 S6EIBAYMO] arson
2) aun Gineseco ten" iw |
| Savax snoinatig 01 o34veroo) 5 we eo — agave pared Taba] 4
‘Sy S11d0ud 40 SOWINITHRA NI
‘3e¥34930 OL ano 5) 3aNMA SH
18194 + uum oN oxa6uex ) paKordws|
enseovte: pue tea au aic}aq S8UteS| wud
‘suvaa se “a
‘SNoWIaNA OL O3evAHIOD SY TVS NI
3ey2u920 O1 ANSI BONA.
co suoe805
{Woy anunoy ono xe 948 1014 19
ww fez ua
losouny
(Way arcana Fan ne
ve ° ws ee eiBoza stayscehoreheal
Voy BERNER OL aay oy
ww pe one ar eiasor pur Baseda) oens
rosy SbesNeoNCBONEN Loe ey
a wea shonau|™SE ee te i; zikouanr boo] :
oua3uvanoa sv Sa5™i08Na| | + f2euana swusdions 81009 10 i
Ni 3e¥aNONIOL 3nd $1 BONSKaVA 3H |
‘Suva SNOIASHA OL GaYaNOD|FEE Tore weed T farba) 4
'5¥ S1iJ0}4 40 JO¥LNISuaE i seam oueeusy00r Xe aye OHS ia}
3g yg4037 OF 3nd 61 BONeIEN 3H +
f vw Ww we t ———=
{ !
: i
| Z I 1
\ Ww 9 wr va
‘SUYEA SNOIATUd O1 GaN aROD! HET (see [rr
ave NI 36¥3H030 MUNWLON
(043910 St 3oNvRYA
oueuen desma: Kueiepuey
spuspen sy evoston
| ‘Sv SUL 930 ONY SZGNVTVO!
PRAT Fae wa waz
eve popu ak uy 10
oT HNOTET DOBOEAN
Cie py 1a-. ANPHAR LABORATORIES PRIVATE LIMITED
” NOTES TO FINANCIAL STATEMENTS
1, STATEMENT OF SIGNIFICANT ACCOUNTING POLICIES TO THE STANDALONE
FINANCIAL STATEMENTS
11 INTRODUCTION
The company is incorporated as a private limited company on under CIN
U33i12)K1987PTC000930 on “potas The company is doing the business of
manufacturing of chemicals. 'Th¢ company is owned and managed by the Directors Sh
Anil Gupta and Sh Ankit Gupta
1.2 Basis of Accounting
These consolidated financial stdtements have been prepared under the historical cost
convention on accrual basis in accordance with the Generally Accepted Accounting,
Principics in India. GAAP Comprises mandatory accounting standards as prescribed
under section 133 of the comp Act, 2013 (‘Act’) read with Rule 7 of the companies
(Accounting) Rules, 2014. Accounting policies have been consistently applied except
where a newly issued account standard is initially adopted or a sevision to an existing
accounting standard requires a change in the accounting policies hitherto in use
1.3. Inventories
Raw materials, packing materials, stores, spares and consumables are valued at lower of
cost, of net realizable value, Cost includes taxes and duties and other incidental expenses
but excludes taxes and duties that are subsequently recoverable from taxing authorities.
ished goods and work-in-prpcess are valued at lower of cost or net realizable value
Cost includes materials, labor and a proportion of appropriate overheads. Cost of
materials has been determined on first in first out basis.
1.4 Property, Plant and Equipment
Property, Plant and Equipment are stated at cost less accumulated depreciation,
impairment, if any. Direct costs pre capitalized until such assets are ready for use.
15 Depreciation and Amortization
Depreciation on tangible assets js provided on Written down Value in accordance with the
provisions of the Companies Aft, 2013 based on the useful lives of assets specified in Part
Cof the Schedule If of the Companies Act, 2013,I
ANPHAR LABORATORIES PRIVATE LIMITED
Nt OTES TO FINANCIAL STATEMENTS
1 Building Ie 30°Yrs
j
3. Plant &quipments | 15 Yrs
4, Furniture & Fixture : 10 Yrs
5 Electrical Equipments - (5 Yrs
6 Laboratory Equipments - 10 Yrs
7, Computer & Printers/-Intercoms 03-06 Yrs
1.6 Impairment of Assets
‘Aveach Balance sheet date, the Company assesses whether there is any indication that
fixed assets with finite lives may be impaired, If any such indication exists, the
recovecable amount of asset ib estimated in order to determine extent of the
impairment, if any, Where it is not possible to estimate the recoverable amount of
individual asset, the Company estimates the recoverable amount of the cash
generating unit to which the assdt belongs.
As of March 31, 2023, none of the fixed assets were considered impaired
1.7 Revenlue Recognition
Revenue from sale is normally recognized on dispatch of goods to customers. Sales are net
of sales returns and trade dixcquats. All expenses are charged to the statement of profit
and loss as and when they are incurred, Provisions are made for all known losses and
liabilities, Expenses reimbursed or subsidies received from the government are shown as
net from expenses
1.8 Employees Benefits
Short ‘Term
Employee benefits are all fornjs of consideration given by an enterprise in exchange of
services tendered by employdes. Short term Employee benefits include items such as
waxes, salaries and socia! sedurity contributions ete and the expected cost of bonus.
Defined contributions in vespgct of Provident fund are made to funds maintained and
administered by the government at stipulated rates. Such contributions are charged to the
statement of profit and loss of the year in which the contributions to the respective funds
ail duc,
Long Term
In accordance with the provisions of the Employees Provident Funds and Miscellaneous
Provisions, 1952, eligible employees of the company are entitled to receive benefits with
respect to Provident Fund, a defined contribution plan in which both the company and(
ANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS
the employee contribute monthly at a determined rate (currently 12.00% of employee's
basic salary) Company's contribution to Provident Fund is charged to the profit & Lost
Account.
Also leave encashment is being accounted for on payment basis at the time of retirement
of the employee and is being recognized as expense in the year of payment, Since the
liability on account of leave che is not very significant therefore no provision has
been made for the amount dve ab such.
Gratuity Plan
The following table set out the status of the Gratuity Plan as required under AS 15.
Reconwitiation of Opening and closing balances of the present value of the defined benefits
obligation and plan assets! .
Pasti Asat
Particulars Mare 31, 2023 _
Obligations at year beginning 2038267
Seevice Cost 1265.07
Interest Cost ua7774
Actuarial (gain)/ loss on obligations (408.52)
Benefits Paid (605.77)
Obligations at year end antag
Defined benefits obligation liability as at the balance sheet date is fully funded by the Company.
Change in plan assets
lau assets at year beginning, at fajr value 23029.68
Expected return on plan assets 1580.55
Actuarial (gainy/loss on plan assets 00
Contributions 97616.62
Benefits paid (605.77)
Plan assets at year end, at fair value 24980.63_
Reconciliation of present value of the obligation and the fait value of the plan assets
Present value of obligations as at the end of the year 2101.19
Fair valve of plan assets at the end of the year 24980.63
Re- Imbursement (vbligation)/.assdis*
Assetl(Liability) Recognized in the balance sheet
Net gratuity cost for the year ended comprises of the following components: __
Particulars Year ended
March 31,2023
Gratuity cos
Service cost 1265.07". ANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS
1.0
wy
Interest cost | 3477.74
Expected retuen on plan assets (458055)
Net Actuarial (gain)floss recognized in the year (403.52)
Flan amendment amortization |
Net Gratuity cost j
(Revised) on “Employee Benefits” effective January 01, 2007. Since the amount of
contribution made to planned assets is more than 1/5th of the actuarial loss, hence, no
adjustment is required
‘The estimates of future salary increases, considered in actuarial valuation, taking account
of inilarion seniority, promotion|and other relevant factors such as demand and supply in
the employment market
Since the impact of reversal of Net Gratuity cost Rs.75,
Hence no provision has been made during the year.
‘The service cost includes the ce of implementation of Accounting Standard AS-15
is not much in the péel A/c
Company is in process of registration of Gratuity Trust for Employees Group Gratuity
Assurance Scheme entered info with the Life insurance Corporation of India (LIC)
trustees with the Income Tax department as on the date of audit
Cask and Cash Equivaients
Cash. and cash “equivalents comprise cash and cash on deposit with banks and
corporations
‘Taxes on Income
Provision for taxation comprises of Current Tax and Deferred Tax, Current Tax
provision has been made on the basis of reliefs and deductions available under the Income
Tax Act, 1961, Deferred tax rasulting from “timing differences” between taxable and
accounting income is accounted for using the tax tates and Jaws that are enacted or
substantively enacted as on the balance sheet date. The deferred tax asset is recognized
and cacsied forward only {o the extent that there is a reasonable certainty that the assets
can be realized in futnee,
Borrowing Costs
As the fixed assets purchased were ready for intended use at the time of purchase itself,
none of the assets are sulin assets, hence the borrowing costs are charged to
Statement of Profit é LossANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS
4.22 Provisions, Contingent Liabilities, Contingent Assets and Significant Events Occurring
after Balance Sheet Date:
A provision is recognized when) an enterprise has a present obligation because of past
events. It is probable that an outflow of resources will be required to settle the obligation,
in respect of which a reliable estimate can be made. Provisions are made based on best
estimates required to settle the obligation at the balance sheet date. These are reviewed at
each balance sheet date and adjusted to reflect the current best estimate. Contingent
liabilities and significant events occurring after balance sheet date are not recognized but
ate disclosed in the notes. Cont}ngent assets ate neither recognized nor disclosed in the
consolidated financial statements
1.13 1.8 Government Grants |
|
The unit is eligible for budgetary support of GST as per J&K Industrial Policy dated 19-04-
2021 (Order No 117-Ind of 2021) and accordingly the claim of Rs 3.33 {acs has been
recognized for the year ending 01-04-2022 to 31-03-2023.
1.14 Effects of changes in Foreign Exchange Rates
Foreign currency transactions are recorded in the reporting currency, by applying to the
foreign curvency amount the exchange rate between the reporting currency and foreign
currency at the date of the transaction.
Foreign currency monetary items are reported at year-end rates, Non-monetary items
which are carcied in terms of historical cost denominated in foreign currency are reported
asing the exchange rate at the date of the transaction:
1
Exchange differences arising on the settlement of monetary items or on reporting
monetary items of Company at rates different from those at whick they were initially
recorded during the yea, or ee in previous financial statements, are recognized as
income or as expenses in the Profit and Loss account in the year in which they arise.
Foreign currency transactions are accounted on the transaction date at RBI reference rate
and the foreign currency liability as on the Balance sheet date has been reinstated to
dian rupees at the RBI reference rate as on that dateANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS:
Detail of foreign exchange ye and outflow has been provided as follows:
Foreign Exchange Earnings (Inflow) Rs 593068.79
15 Statement Showing Quantitative Details of Finished Goods :
Units Quantity
{ | Kes 971
| Cniloride HCL 1PmR/USP, _Amitsalpside|
IP/BP/EP, Chlorpromazine ICL. IP/BP, |
| Haloperiodol IP/BP etc.) |
Closing Stock fp Kes — (755
[amiloride HCL IP/BP/USP, Amilsulpride
1P/BP/EP, Chlorpromazine HCL ine
|
| Haloperiodol IP/BP etc.)
Sales Kes 115012
| (Amiloride HCL TP/BP/USP, | Anime
IP;BP/EP, Chlorpromazine HCL. IP/BP, |
| Haloperiodol IP/BP etc.) |
1.16 Raw Material Consumption. (Maj jor Items)
| Material Name "| Units
Bromo Chio: Tes
a
| 2.2 Chloro Ethoxyethanol ike
| 2-Ftiftuoro Methly Phenothaizine|(2-TP2) TKes
| Guanidine HC i Kgs
‘hly: Piperaine (TFPP)ANPSAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS
| ee
dium Methly Crystals | Kgs
-5-NITROSO,2-4 DIHYDROXY | Kgs
PYRIMIDINE 6 AMINO) |
GLYOXAL ee aa + Kgs |
4 ae ef
1.17 Remuneration to Directors
Details of remuneration paid to oer are given below:
Name of the Directors Nature of Transactions Remuneration paid
2022-23
Anil Gupta Salary Rs.86000.00
Ankit Gupta Salary Rs.60000.00
Avil Gupta Bonus Rs, 7000.00
Ankit Gupta Bonus Rs, 5000.00
1.18 Related Party Disclosures
Details of Related Parties =
Anil Gupta Director
Ankit Gupta Director
Shammi Gupta Wile of Director
Arpita Gupta Daughter of Director
Agrotech Aromatics Private Lid. Subsidiary Company
(CIN;U9L409JK 1996PTCOOTS)4)
Details of Dealing with Related Parties
NAME OF PARTY NATPRE OF TRANSACTION AMOUNT (2022-23)
Arpita Gupta Salary Rs. 6000.00
Ankit Gupta Rent Rs, 1200.00
Agrotech Aromatics Pvt. Ltd. Corporate Loan Rs 231500,00 ©ANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS
1.19 Deferred Tax Asset |
Deferred tax Liability FY 2022-23
{amount 00's)
Total WDV as per Income Tax Act Rs 668701.28
| Total WDV as per Companies Act | Rs 616723.83
| Difference Tt Rs 51977.44
| Deferred Tax Asset @26% (A) Rs 13082,72
‘Opening Deferred Tax Liability Rs 9580.29
Provision for Deferred Tax (Transferred to Profit & loss Rs 3502.42
account)
l -
1.20 List of Shareholders holding more than 5% shareholding:-
Shareholders No. of Shares
Anil Gupta 500000. shares
Arpita Gupta 178362 shares
Shammi Gupta 125000 shares
Ankit Gupta 265852 shares
Sukriti Sharma 119866 shares
1.21 Disclosure of Operating Lease |
Disclosure in respect of Land taken on lease 2022-23, 2021-22
a) lease payment projected in the Profit & Loss A/c 900.00 900.00
b) future minimum lease Pajments under non-cancellable operating lease in the
aggregate and for each of thel following periods:
i, not later than one year; 900.00 900.00
ii, later than one year end'not later than five years: 1000.00 1900.00
iii, later than five years 1000.00 1900.00
©) Significant easing agreements:
erenewal of lease deed after 2026ANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL SnfTEMEnrs
1.22 Earnings por Share
Basic earnings per shate is calculafed ted by dividing the net consolidated profit or loss for
the period aitributable to equity shareholders by the weighted average number of equity
shares outstanding during the period
For the purpose of calculating diluted earnings per share, the net consolidated profit or
loss for the period attributable tg equity shareholders and the weighted average number
of shaves outstanding during the period are adjusted for the effects of all dilutive potential
equity shares.
1.23 Corporate Social Responsibility (CSR)
As per Section 135 of the companies act,2013, a company, meeting the applicability threshold,
needs to spend al least 2% of its ayerage net profit for the immediately preceding three financial
‘years on corporate social responsibjtity (CSR) activities.
Pursuant lo the MCA nolificatipn daied 20.09.2022, the company is exempted from the
compliance under section 135 of tile Companies Act, 2013 and hence the company has not made
any spending towards CSR duting,the year 2022-23.
1.24 Miscellaneous
+ There is no privr-periot or extraordinary item of income/expenses credited/
debited to the Profit & Lass Account.
impact in the current
year or in the following year.
+ Previous years’ figures have been re-grouped and re-arranged wherever
considered necessary
1.25 Notes on Financial Statements
1 The details of Managerial Remungration paid to Directors is as follows =
« There is no change in a policy which has a mater
Current Year
8700.90
[Name of the Directo
| Anit Gupta
' Ankit Gupta
59500.00
2. Trade veceivables , rade payables , Loans and Advances and Unsecured Loans have_been
laken at their book Value subject tv confirmation and ceconciliation. Loans and Advances are
considered good in respect of which «
mpany does not hold any security other that the
persnnal Guarantee of persons.ANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS,
|
3. Payment to Auditors 2
| Particulars — T 1 Curent Year Previous Year
| Statutory Audit fee
7 380.00 850.00
| |
|
L an |
‘In the opinion of the management the value on realization of current assets, Loans and
Advance in the ordinary course of usiness , will not be less,than the value at which these are,
stated in the Balance Sheet.
5. The SS) status and MSME status of the creditors has not been intimated to the company
thence the information is not given
7. Parsivant to the Taxation Laws ( Amendment Act 2019 ,, with effect from 01-Apr-2019
domestic companies have the optjan te pay Corporate income fax 4 22% plus applicable
surcharge and cess! New Tax a subject to certain conditions. The company has adopted
new scheme from the.applicabie year
2. The company does not have any Benami property, where any proceedings has been initiated
or pending against the company fof holding any Benami property.
3. The Company does not have any transactions with the Companies struck off,
4. The company does not have any charges oF satistaction which is yet to be registered with ROC
beyond the statutory period.
5, The company has riot traded o invested in Crypto currency or Virtual currency ditring the
financial period
6. The Company has not advanced of loaned oF invasted funds te any other person(s) or entity(
ies), including foreign entities ({otermediaries} with the understanding that the intermediary
]
shall
a) directly or indirectly lend or ijvest in other persons or entities identified in any manner
whatsoever by or on behalf of the Company Ultimate Beneficiaries ) or
{b) provide security or the like te ar on behalf of the Ultimate Beneficiaries
7. The company has not received only fund from any person(s) or entity (ies). includiag foreign
entices ( Funding Parly ) with the understanding, ( whether recorded in writing or otherwise)
fixat the company shall |
1) directly oF inctirectly lend or ihvest in other persons or entities identified in any manner
whatscaver by or on behalf of the Funding Party ( Ultimate Beneficiaries )
b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries,
3. The Company does not have any transaction which is not recorded in the books of accounts
that lias beer surrendered or disclosed as income duting the year in the ta: (such as, search or
survey or any ather relevant provisions of the Income Tax Act. 1961)ANPHAR LABORATORIES PRIVATE LIMITED
NOTES TO FINANCIAL STATEMENTS
9. The Company has not been declared willful defaulter by any bank of financial Institution or
other lender }
10, The Company does not have any Sdheme of Arrangements which have been approved by the
Competent Authority in terms of seftions 230 to 237 of the Act.
U1, The Company has complied with the number of layers presctibed under of Section 2(87) of
the Act read with the Companies (Restriction on number of Layers) Rules, 2017.
12, In March 2020 the World Healt Organisation dectared COVID 19 to be a pandemic.
Consequent to this, Government of India declared a national lockeown on 25 March activities
of the Company . The Company has assessed the impact that may result from this pandemic
on its liquidity position , carrylng amounts of other relating to the possible future
uncerfainties in the global economic conditions because of this pandemic , the Company has
considered internal and of approval these financial statements and has assessed its situation
13, in that context and based on the dunvent estimates, the Company believes that COVID 19 is
not likely to have any material fmpact on its financial statements , liquidity or ability to
service ite debt or other obligations. However , the oveall eronomie environment, being
unceslain due to COVID 19, may affect the underlying assumptions and estimates in future ,
which may differ fram those consitlered at the date of approval of these financial statements
date of approval of these financia statements , The Company would closely monitor suck
developments in future economic conditions and consider their impact on the financial
Statements of the relevant periods,
U4, The Audit Trail applicability dite has been extended to 01/04/2023 by the Companies
(Accounts) Second Amendment! Rules, 2022 dated 31/03/2022.
As per our Report of even date
For Arora Vohra & Co, For and on behalf of the Board of Directors
Chartered Accountants
Firm Regn, No. Co
CA. Karah Bir Singh} nt oupta Gupta Ankit Gupta
(Partner) (Managing Director) (itecto:)
Membership No. 091388 DIN:06897796 DIN:08782i80
Place: Jamuna
Date : 04/09/2023,